NCT05768724 is a NA clinical trial of intervention diet in Polycystic Ovary Syndrome, sponsored by Gazi University.

Who is sponsoring NCT05768724?

NCT05768724 is sponsored by Gazi University.

What drugs are being tested in NCT05768724?

Interventions in NCT05768724: intervention diet, control diet.

What condition does NCT05768724 study?

NCT05768724 studies Polycystic Ovary Syndrome, Obesity, Androgen; Hypersecretion, Diet, Healthy.

Is NCT05768724 still recruiting?

NCT05768724 is currently completed. Last updated 14 March 2023.

Last reviewed 2023-03-14 · How we verify

NCT05768724

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Two Different Dietary Interventions for Girls With Polycystic Ovary Syndrome

Completed NA Last updated 14 March 2023

What this trial tests

NA trial testing intervention diet in Polycystic Ovary Syndrome in 40 participants. Completed in 1 February 2022.

Timeline

1 January 2021

Primary endpoint
5 December 2021

1 February 2022

Quick facts

Lead sponsor	Gazi University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	treatment
Enrollment	40
Start date	1 January 2021
Primary completion	5 December 2021
Estimated completion	1 February 2022
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

intervention diet
control diet

Conditions studied

Polycystic Ovary Syndrome — all drugs for Polycystic Ovary Syndrome →
Obesity — all drugs for Obesity →
Androgen; Hypersecretion — all drugs for Androgen; Hypersecretion →
Diet, Healthy — all drugs for Diet, Healthy →

Sponsor

Gazi University

Who can join

Adults 13 to 18, female only, with Polycystic Ovary Syndrome or Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study was conducted to evaluate the efficacy of the MEtabolic Syndrome REduction in NAvarra (RESMENA) diet versus a control diet based on American Heart Association (AHA) recommendations for the treatment of PCOS in adolescents with obesity and PCOS. A total of 40 adolescents diagnosed with PCOS between the ages of 13-18 years were randomized to either a Resmena or control diet for 6 months. Dietary status, anthropometry, body composition, biochemical parameters, and reproductive endocrine hormones were compared between the 2 groups before and after the intervention.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Beneficial Effects of RESMENA Diet on Anthropometric, Metabolic, and Reproductive Profile in Adolescents with Obesity and Polycystic Ovary Syndrome: A Randomized Controlled Intervention Study.
Bozbulut R, Döğer E, Çamurdan MO, Bideci A. · · 2024 · cited 2× · PMID 37952514 · DOI 10.1159/000535053

Verify or expand the search:

Other recruiting trials for Polycystic Ovary Syndrome

Currently open trials in the same condition.

NCT07591246 — Efficay of Physical Activity Program in PCOS Females With Fatty Pancrease and Thyroid Hypofunction · NA · recruiting
NCT07446985 — Is There a Benefit From Addition of Physical Exercise to Diet Restriction/Limitation in PCOS Women With Asthma? · NA · recruiting
NCT07385716 — Evaluation of the Effect of Time-Restricted Feeding and Mediterranean Diet Model in Women With Polycystic Ovary Syndrome · NA · recruiting
NCT07366944 — PCOS and Problem of Eye Dryness: Is There a Benefit From Lifetyle Changes · NA · recruiting
NCT07289399 — Is There a Benefit From Addition of Treadmill Walking to Diet Restriction in Psoriasis Women With PCOS? · NA · recruiting

Other Gazi University trials

Trials by the same sponsor.

NCT07500857 — Gamification in Stoma Care Education for Nursing Students · NA · not yet recruiting
NCT07471737 — Patient Safety and Medical Errors in Nursing Education: Learning by Doing and Experiencing With Simulated Patients · NA · not yet recruiting
NCT07440563 — Auricular Vagus Nerve Stimulation Combined With Rehabilitation in Parkinson's Disease · NA · enrolling by invitation
NCT07496398 — Median and Ulnar Nerve Function in Tattoo Artists · recruiting
NCT07471386 — Adjunctive Keratinized Mucosa Augmentation in Peri-Implantitis · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05768724 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Gazi University
Last refreshed: 14 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05768724.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing